April 1, 2024
 
 

Small Stocks, Big Money™

Weekly Newsletter
REDCHIP.COM
 
 
Biotricity Accelerates Market Access by Partnering with Third Major Group Purchasing Organization, Expanding Market Reach to 90% of U.S. Hospitals
 
Biotricity (Nasdaq: BTCY), a leading Technology-as-a-Service (TaaS) company revolutionizing the medical diagnostic and consumer healthcare field, continues its strategic expansion with the announcement of its latest partnership with yet another leading Group Purchasing Organization (GPO). GPOs streamline purchasing processes for medical providers and systems. With this latest partnership, Biotricity's GPO partners collectively manage the buying needs of 9 out of every 10 hospitals in the U.S. Moreover, they wield immense purchasing power, totaling $264 billion. With these strategic alliances, Biotricity is poised to drive growth by capitalizing on these expansive market channels, solidifying its standing as a premier player in the healthcare technology sector.
 
 
 
 
 
 
 
 
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
 
Nutriband (Nasdaq: NTRB), a company engaged in the development of prescription transdermal pharmaceutical products, provided an overview of the clinical development and regulatory pathway for its lead product, AVERSA™ Fentanyl, an abuse-deterrent fentanyl transdermal patch. Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband's AVERSA™ abuse-deterrent transdermal technology into Kindeva's FDA-approved transdermal fentanyl patch system. As a result, the 505(b)(2) New Drug Application (NDA) will be primarily based on a single Phase 1 human abuse potential clinical study with no Phase 2 or 3 clinical trials needed.
 
 
 
 
 
 
 
American Resources Corporation's ReElement Technologies Announces Successful Execution and Closing of Bond Purchase Agreement for $150 Million of Kentucky Industrial Building Revenue Bonds for its Kentucky Lithium Refinery
 
American Resources Corporation's (Nasdaq: AREC) subsidiary, ReElement Technologies Corporation, a leading provider of high-performance refining capacity of rare earth and critical battery elements, announced that it has successfully executed and closed a Bond Purchase Agreement with Hilltop Securities Inc. for $150,000,000 principal amount of Kentucky Industrial Building Revenue Bonds, Series 2024, for the Company's Kentucky Lithium LLC complex located near the town of Kite, Kentucky.
 
 
 
 
 
 
 
 
 
 
Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting
 
Reviva Pharmaceuticals (Nasdaq: RVPH), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will be presenting a poster at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2024 Annual Meeting, to be held in Colorado Springs, CO, USA on March 27-29, 2023.
 
 
 
 
 
 
 
GreenPower Announces Results of Annual General and Special Meeting, Appointment of Officers, Stock Option Grants and Appointment of Investor Relations Representative
 
GreenPower Motor Company Inc. (Nasdaq: GP), a leading manufacturer and distributor of purpose-built, all-electric, zero-emission medium and heavy-duty vehicles serving the cargo and delivery market, shuttle and transit space and school bus sector, announced the results of the Annual General and Special Meeting (AGM) that was held on March 27, 2024.
 
 
 
 
 
 
 
Small Stocks, Big Money™ Podcast
 
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
amazon music apple music spotify music
 
 
 
 
 
 
Upcoming Events
 
 
4
 
 
Apr 2024
 
NASDAQ: BTCY - Biotricity
4:15pm Eastern
 
Biotricity is a pioneering medical technology company delivering a full suite of remote diagnostic and remote patient monitoring hardware solutions which integrate with powerful and proprietary software solutions to deliver state-of-the-art cardiac care to patients.
 
 
 
 
 
 
 
Archived Events
 
 
27
 
 
Mar 2024
 
NASDAQ: LYT - Lytus Technologies
4:15pm Eastern
 
Lytus is a rapidly growing Platform IT services company. It currently has over 4 million active viewers and users in India. It is a rapidly growing online content and streaming service providers in India.
 
 
 
 
 
 
Quote of the Week
 
"If you are going to use probability to model a financial market, then you had better use the right kind of probability. Real markets are wild."
— Benoit B. Mandelbrot, The Misbehavior of Markets
 
 
RedChip TV
 
 
 
 
RedChip TV Highlights LOBO EV (NASDAQ: LOBO) & BIOTRICITY (NASDAQ: BTCY) This Week
 
 
 
 
 
 
 
Genetic Technologies: Innovating Healthcare with Genomics-based Cancer Predictions
 
 
 
 
 
 
 
Biotricity: Revolutionizing Cardiac Care & Market Share | Cutting-Edge Solutions & Growth
 
 
 
 
 
 
 
Order "Small Stocks, Big Money™ Today!
 
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
 
 
 
 
 
 
 
Lesson of the Week
 
Dollar cost averaging is a great way to minimize the volatility of long-term investments.
 
 
 
 
 
 
 
MidSouth Week in Review
 
Bitcoin recovered to $71k from $63k last week. Gold rose to $2,236 from $1,800 in October.